NASDAQ:CDNA CareDx Q3 2026 Earnings Report $65.41 -4.44 (-6.36%) As of 12:29 PM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast CareDx EPS ResultsActual EPSN/AConsensus EPS $0.24Beat/MissN/AOne Year Ago EPSN/ACareDx Revenue ResultsActual RevenueN/AExpected Revenue$121.95 millionBeat/MissN/AYoY Revenue GrowthN/ACareDx Announcement DetailsQuarterQ3 2026Date11/3/2026TimeAfter Market ClosesConference Call DateTuesday, November 3, 2026Conference Call Time4:30PM ETConference Call ResourcesEarnings HistoryCompany Profile CareDx Earnings HeadlinesCareDx (NASDAQ:CDNA) Hits New 12-Month High - What's Next?October 5 at 1:01 PM | americanbankingnews.comAnalyzing CollPlant Biotechnologies (NASDAQ:CLGN) and CareDx (NASDAQ:CDNA)October 5 at 10:14 AM | americanbankingnews.comThis smart glasses tech is bringing the screen to your eyesGlobal AI smart-glasses shipments surged 263% in the first half of 2026, and Citi projects the market could reach 112 million pairs annually by 2030. One NASDAQ-listed American company has spent nearly three decades developing the waveguide technology that makes see-through displays possible. It is already moving into initial production with RTX subsidiary Collins Aerospace for soldier-worn displays, with applications expanding well beyond defense.October 6 at 1:00 AM | The Tomorrow Investor (Ad)CareDx (NASDAQ:CDNA) Hits New 1-Year High - What's Next?September 30, 2026 | americanbankingnews.comCritical Survey: Ascendis Pharma A/S (NASDAQ:ASND) & CareDx (NASDAQ:CDNA)September 29, 2026 | americanbankingnews.comCareDx: I Was Wrong, But The Rally Has Outrun The Fundamentals (Rating Upgrade)September 25, 2026 | seekingalpha.comSee More CareDx Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like CareDx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CareDx and other key companies, straight to your email. Email Address About CareDxCareDx (NASDAQ:CDNA) (NASDAQ: CDNA) is a precision-medicine company focused on improving the care of organ-transplant patients. The company develops diagnostic tests, digital tools and services designed to help clinicians monitor transplant recipients, assess the risk of rejection and support long-term graft management. CareDx’s product portfolio includes AlloMap, a gene-expression blood test used in heart-transplant surveillance, and AlloSure, a donor-derived cell-free DNA test designed to help detect potential organ injury or rejection. The company also offers HeartCare, which combines AlloMap and AlloSure for heart-transplant monitoring, as well as transplant-focused testing and care-management solutions for kidney and other transplant populations. CareDx has its roots in the development of molecular diagnostics for transplant medicine and serves transplant centers, physicians and patients primarily in the United States, with select products and services available in international markets. Its offerings are intended to complement clinical evaluation and help reduce reliance on more invasive monitoring procedures.View CareDx ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles AI Chip Demand Gives Linde a New Growth Catalyst3 Low-Rated Stocks Analysts May Be Underestimating Ahead of Q3 EarningsNVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can RunMarketBeat Week in Review – 09/28 - 10/02Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?Time to Nibble on MCD Stock After it Enters Oversold Territory?Liberty Energy’s AI Power Push Has Wall Street Divided Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
